Fischer Medical Ventures is planning to raise funds by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company. A meeting of the Board of Directors of the Company is scheduled to be held on January 03, 2025, inter alia, to consider and approve the same.
Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.
